CHICAGO, IL—A novel in vivo gene-editing therapy based on CRISPR-Cas9 that targets inactivation of the transthyretin (TTR) gene could slow disease progression in patients with cardiomyopathy caused by ...
Meet Raymond and Alan, two people diagnosed with transthyretin cardiac amyloidosis (ATTR-CM), a rare and underdiagnosed cause of heart failure. 1 Both led active, healthy lives before experiencing ...
Everyday Health on MSN
ATTR-CM and vitamin A supplementation: What you need to know
ATTR-CM affects the protein in your body that carries vitamin A where it needs to go, and ATTR-CM treatment can cause very ...
Editor’s note: This is an automatically generated transcript. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription. Well, after the treatment for transthyretin ...
Transthyretin amyloid cardiomyopathy (ATTR-CM) is a disease that causes a blood protein called transthyretin (TTR) to build up in your heart, nerves, and potentially other organs. TTR proteins aren’t ...
Taking care of someone with cardiac amyloidosis can be challenging, but you’re not alone. In people with ATTR-CM, proteins called amyloids build up in the heart, which stiffens the muscle over time.
PALO ALTO, Calif., May 12, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on genetic diseases, announced ...
Editor’s note: This is an automatically generated transcript. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription. Well, transthyretin cardiac amyloidosis is ...
BridgeBio Pharma, Inc. announced that it will present research findings related to its drug acoramidis for treating variant transthyretin amyloid cardiomyopathy (ATTR-CM) at the upcoming Annual ...
Open-label extension data from 389 ATTRibute-CM completers compared continuous acoramidis with placebo-to-acoramidis crossover, after mandated tafamidis discontinuation. Continuous acoramidis exposure ...
Heart failure can be a scary diagnosis. But what if there’s something else going on that’s even harder to spot? Meet transthyretin cardiac amyloidosis (ATTR-CM)—a serious heart condition that is ...
Hereditary transthyretin amyloid cardiomyopathy (hATTR-CM) is an inherited heart condition in which protein buildup in the heart muscle causes it to stiffen and thicken, often leading to heart failure ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results